FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Zydus Pharmaceuticals (USA) Esomeprazole Magnesium for Delayed-Release Recall

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
May 28, 2025
Recall ID
D-0442-2025
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Esomeprazole Magnesium for Delayed-Release starting May 13, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0442-2025 on May 28, 2025. Reason: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

Product description

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94

Lot numbers, UPCs & expiration codes

Lot # M311638, Exp 07/2025, M400374, Exp 10/2025, M402496, Exp 02/2026, M407998, Exp 05/2026, M502247, Exp 11/2026, M414770, M414512, Exp 09/2026.

Where it was sold

Nationwide -in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0442-2025
Classification
Class II
Status
Ongoing
Recall initiated
May 13, 2025
FDA report date
May 28, 2025
Quantity
30,674 30 sachets/carton
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0442-2025, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Ongoing
Country
United States
Event ID
96860
Address
73 Route 31 N
Code information
Lot # M311638, Exp 07/2025, M400374, Exp 10/2025, M402496, Exp 02/2026, M407998, Exp 05/2026, M502247, Exp 11/2026, M414770, M414512, Exp 09/2026.
Postal code
08534-3601
Report date
May 28, 2025
Product type
Drugs
Recall number
D-0442-2025
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
30,674 30 sachets/carton
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94
Distribution pattern
Nationwide -in the USA
Recall initiation date
May 13, 2025
Initial firm notification
Letter
Center classification date
May 20, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0442-2025, published May 28, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls